According to Coherent Market Insights, the global degenerative disc disease treatment market was valued at US$ 1,736.4 million in 2019 and is expected to exhibit a CAGR of 9.0% over the forecast ...
Reoperation rates between cervical disc replacement and anterior cervical discectomy and fusion didn’t see significant differences in reoperation risks. However disc replacement had some advantage in ...
MELVILLE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical ...
Degenerative disc disease (DDD) and intervertebral disc degeneration (IVDD) represent conditions that impair the function of the spinal motion segments, profoundly affecting quality of life worldwide.
Intradiscal injection of BRTX-100 during an outpatient procedure is expected to alleviate chronic low back pain arising from the damaged disc. The Food and Drug Administration (FDA) has granted Fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback